Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 2/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 2/20 | 0.31 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | PRF1 | P14222 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21546907 | 0.89 | PGR (0.37) | PGRGRM5TNKSCSNK2A2CSNK2B | |
| SCHEMBL21546996 | 0.88 | PGR (0.37) | PGRPTPN5PDK2ENPP1PDPK1 | |
| SCHEMBL21547162 | 0.87 | ENPP1 (0.33) | PGRPDK2ENPP1PRF1 | |
| SCHEMBL21188802 | 0.87 | PGR (0.37) | PGRGRM5TNKSCSNK2A2CSNK2B | |
| SCHEMBL22760773 | 0.87 | MAT2A (0.35) | PGRPTPN5ENPP1PDPK1TNKS | |
| SCHEMBL22760763 | 0.86 | ENPP1 (0.34) | PGRPTPN5PDK2ENPP1PDPK1 | |
| SCHEMBL21546735 | 0.85 | ENPP1 (0.34) | PGRPTPN5PDK2ENPP1PRF1 | |
| SCHEMBL21546461 | 0.84 | PGR (0.35) | PGRGRM5TNKSCSNK2A2CSNK2B | |
| SCHEMBL20617098 | 0.83 | RXRA (0.35) | PDPK1TNKSADORA2A | |
| SCHEMBL22761171 | 0.82 | PTPN5 (0.43) | PGRPTPN5PDK2ENPP1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981930-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-04-20 | — | — | US | disclosed |
| US-20200385399-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-10 | — | — | US | disclosed |
| EP-3478793-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981930-B2 | Organic molecules for use in optoelectronic devices | OR10J3, OR51E2, EPCAM | PGR 3398/4885PTPN5 4550/4885PDK2 2517/4885 |
| US-20200385399-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OR51E2, EPCAM | PGR 3398/4885PTPN5 4550/4885PDK2 2517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.